Search
Prestige Consumer Healthcare Inc
PBHAdd to Watchlist
50.220USD
+0.295+0.59%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.38BMarket Cap
12.79P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Prestige Consumer Healthcare Inc is 8.00, ranking 56 out of 155 in the Pharmaceuticals industry. The average price target is 76.00, with a high of 88.00 and a low of 70.00.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
66.000
Target Price
+31.42%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Prestige Consumer Healthcare Inc
PBH
6
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
Pfizer Inc
PFE
32
AbbVie Inc
ABBV
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Prestige Consumer Healthcare Inc's expected revenue for the next quarter?
Prestige Consumer Healthcare Inc's expected revenue is 249.68M.
What is Prestige Consumer Healthcare Inc's price target?
Analysts forecast that Prestige Consumer Healthcare Inc's price target is USD 76.00, with the highest forecast at USD 88.00 and the lowest forecast at USD 70.00.
How have Prestige Consumer Healthcare IncPBH's recent earnings per share performed?
The market expectation was USD 1.14, while Prestige Consumer Healthcare IncPBH's earnings per share (EPS) for the previous quarter was USD 0.98. EPS for the next quarter is expected at USD 0.88.
What is the analyst rating for Prestige Consumer Healthcare Inc?
Based on the ratings of Prestige Consumer Healthcare Inc's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.